Association of myocarditis with BNT162b2 messenger RNA COVID-19 vaccine in a case series of children
JAMA Aug 15, 2021
Dionne A, Sperotto F, Chamberlain S, et al. - Researchers described a small case series of children diagnosed with myocarditis after COVID-19 vaccination. In this case series, patients exhibited a benign short-term course; however, uncertainty remains concerning the long-term risks.
Fifteen children (14 male patients [93%]; median age, 15 years [range, 12-18 years]) were identified who were hospitalized with myocarditis after receipt of the BNT162b2 messenger RNA COVID-19 vaccine for 1 to 5 days.
Most frequently males were affected after the second vaccine dose.
As per cardiac magnetic resonance imaging, three patients had ventricular systolic dysfunction, and 12 patients had late gadolinium enhancement.
No mortality was recorded.
Normal echocardiogram results were recorded on follow-up 1 to 13 days after discharge in all except 1 patient.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries